Genitourinary Cancer

Metastasis-Directed Therapy Protective in Recurrent Prostate Cancer

By

Jody A. Charnow

Publish Date March 23, 2023

New findings could have implications for the use of salvage therapies.

Survival Improving in Metastatic Bladder Cancer Cases

By

Jody A. Charnow

Publish Date March 23, 2023

Trend may reflect increasing use of systemic immunotherapies as first-line treatments, according to investigators.

Partial Cytoreductive Nephrectomy Still Offers Survival Edge in Metastatic RCC

By

Jody A. Charnow

Publish Date March 22, 2023

In a study, partial vs radical cytoreductive nephrectomy for clear cell metastatic renal cell carcinoma was associated with a 54% decreased risk for other-cause mortality.

Study Could Guide Therapeutic Choices for mCSPC

By

Jody A. Charnow

Publish Date March 21, 2023

A recent systematic review and meta-analysis provides the most up-to-date evidence for performance of triplet therapy compared with API-based doublets in mCSPC.

Low Prostate Cancer-Specific Mortality Seen for Men With Localized Disease

Publish Date March 20, 2023

Prostate cancer-specific mortality was low for men randomly assigned to active monitoring, prostatectomy, or radiotherapy.